Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schleuning

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Transfusion Science|October 18, 2000
Adoptive allogeneic immunotherapy--history and future perspectivesM Schleuning
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie|November 1, 1982
Studies on the excretion of tissue kallikrein from blood into the urineE Fink, M Schleuning
Klinische Wochenschrift|September 3, 1990
Tumor necrosis factor: an update on basic research and clinical applicationsM Schleuning, R Munker
Vox Sanguinis|January 1, 1994
Complement activation during storage of single-donor platelet concentratesM Schleuning, M Böck, W Mempel
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1994
Inhibition of cyclosporin A/FK506 resistant, lymphokine-induced T-cell activation by phenothiazine derivativesM Schleuning, V Brumme, W Wilmanns
Anticancer Research|May 1, 1993
Growth inhibition of human leukemic cell lines by the phenothiazine derivative fluphenazineM Schleuning, V Brumme, W Wilmanns
European Journal of Haematology|March 25, 1999
Bcr-abl protein detection in peripheral blood mononuclear cells for follow-up of chronic myelogenous leukaemia patientsM Schleuning, J Mittermüller, H J Kolb
Cancer Research|July 1, 1989
Immunoregulation and production of tumor necrosis factor alpha by human thymocytesG H Reem, A Duggan, M Schleuning
Infusionstherapie Und Transfusionsmedizin|October 1, 1992
Effects of leukocyte depletion on the formation of anaphylatoxins in stored whole bloodM Schleuning, H Utz, M Heim, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1992
Decreased formation of the complement component C4A in leukocyte-depleted stored whole bloodM Schleuning, H Utz, M Heim, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Transfusion Science|October 18, 2000
Adoptive allogeneic immunotherapy--history and future perspectivesM Schleuning
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie|November 1, 1982
Studies on the excretion of tissue kallikrein from blood into the urineE Fink, M Schleuning
Klinische Wochenschrift|September 3, 1990
Tumor necrosis factor: an update on basic research and clinical applicationsM Schleuning, R Munker
Vox Sanguinis|January 1, 1994
Complement activation during storage of single-donor platelet concentratesM Schleuning, M Böck, W Mempel
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1994
Inhibition of cyclosporin A/FK506 resistant, lymphokine-induced T-cell activation by phenothiazine derivativesM Schleuning, V Brumme, W Wilmanns
Anticancer Research|May 1, 1993
Growth inhibition of human leukemic cell lines by the phenothiazine derivative fluphenazineM Schleuning, V Brumme, W Wilmanns
European Journal of Haematology|March 25, 1999
Bcr-abl protein detection in peripheral blood mononuclear cells for follow-up of chronic myelogenous leukaemia patientsM Schleuning, J Mittermüller, H J Kolb
Cancer Research|July 1, 1989
Immunoregulation and production of tumor necrosis factor alpha by human thymocytesG H Reem, A Duggan, M Schleuning
Infusionstherapie Und Transfusionsmedizin|October 1, 1992
Effects of leukocyte depletion on the formation of anaphylatoxins in stored whole bloodM Schleuning, H Utz, M Heim, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1992
Decreased formation of the complement component C4A in leukocyte-depleted stored whole bloodM Schleuning, H Utz, M Heim, et al.
Pageof 4